Complications of first-trimester abortion by vacuum aspiration after cervical preparation with and without misoprostol: A multicentre randomised trial

The Lancet

Volumn 379, Issue 9828, 2012, Pages 1817-1824

  Meirik, Olav ^a   Huong, Nguyen Thi My ^a   Piaggio, Gilda ^b,c   Bergel, Eduardo ^a   Von Hertzen, Helena ^a,d  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b Statistika Consultoria   (France)

^c Statistika Consultoria   (Brazil)

^d NONE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MISOPROSTOL; PLACEBO;

ABDOMINAL PAIN; ADULT; ARTICLE; CHILL; CONTROLLED STUDY; DIARRHEA; DILATION AND EVACUATION; DIZZINESS; DRUG EFFICACY; FEMALE; FEVER; FIRST TRIMESTER PREGNANCY; HEADACHE; HUMAN; INCOMPLETE ABORTION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NAUSEA; PELVIC INFLAMMATORY DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; SYSTEMATIC REVIEW; UTERINE CERVIX DILATATION; UTERINE CERVIX DISEASE; UTERINE CERVIX TRAUMA; UTERUS PERFORATION; VACUUM ASPIRATION; VAGINA BLEEDING; VOMITING;

EID: 84860839275     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)61937-5     Document Type: Article

References (23)

1. Sedgh G, Henshaw S, Singh S, Ahman E, Shah IH. Induced abortion: rates and trends worldwide. Lancet 2007; 370: 1338-45. (Pubitemid 47539568)
2. WHO. Medical methods for termination of pregnancy. Technical report series no 871. Genveva: World Health Organization, 1997.
3. Pazol K, Gamble SB, Parker WY, Cook DA, Zane SB, Hamdan S. Abortion surveillance-United States, 2006. MMWR Surveill Summ 2009; 58: 1-35.
4. WHO. Safe abortion: technical and policy guidance for health systems. Geneva: World Health Organization, 2003.
5. Bartlett LA, Berg CJ, Shulman HB, et al. Risk factors for legal induced abortion-related mortality in the United States. Obstet Gynecol 2004; 103: 729-37. (Pubitemid 40459035)
6. Hulka JF, Lefler HT Jr, Anglone A, Lachenbruch PA. A new electronic force monitor to measure factors influencing cervical dilation for vacuum curettage. Am J Obstet Gynecol 1974; 120: 166-73.
7. Johnstone FD, Boyd IE, McArthy TG, McClure Browne JC. The diameter of the uterine isthmus during the menstrual cycle, pregnancy and the puerperium. J Obstet Gynaecol Br Commonw 1974; 81: 558-62.
8. Royal College of Obstetricians and Gynaecologists. The care of women requesting induced abortion: evidence-based clinical guideline number 7. Hampshire, UK: RCOG Press, 2004.
9. Allen RH, Goldberg AB, Board of Society of Family Planning. Cervical dilation before first-trimester surgical abortion (<14 weeks' gestation). Contraception 2007; 76: 139-56.
10. Fiala C, Gemzell-Danielsson K, Tang OS, von Hertzen H. Cervical priming with misoprostol prior to transcervical procedures. Int J Gynaecol Obstet 2007; 99 (suppl 2): S168-71. (Pubitemid 350110439)
11. Kapp N, Lohr PA, Ngo TD, Hayes JL. Cervical preparation for first trimester surgical abortion. Cochrane Database Syst Rev 2010; 17: CD007207.
12. Machin D, Campbell MJ, Fayers PM, Pinol APY. Statistical tables for the design of clinical studies. Oxford: Blackwell Scientific, 1997.
13. Haybittle JL. Repeated assessment of results in clinical trials of cancer treatment. Br J Radiol 1971; 44: 793-97.
14. Moher D, Hopewell S, Schulz KF, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trial. BMJ 2010; 340: c869.
15. Schulz KF, Altman DG, Moher D, for the CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010; 8: c332.
16. WHO Special Programme of Research, Development, and Research Training in Human Reproduction, Task Force on Prostaglandins for Fertility Regulation. Vaginal administration of 15-methyl-PGF2 alpha methyl ester for preoperative cervical dilatation. Contraception 1981; 23: 251-59.
17. Chambers DG, Mulligan EC, Laver AR, Weller BK, Baird JK, Herbert WY. Comparison of four perioperative misoprostol regimens for surgical termination of first-trimester pregnancy. Int J Gynaecol Obstet 2009; 107: 211-15.
18. Mittal S, Sehgal R, Aggarwal S, Aruna J, Bahadur A, Kumar G. Cervical priming with misoprostol before manual vacuum aspiration versus electric vacuum aspiration for first-trimester surgical abortion. Int J Gynaecol Obstet 2011; 112: 34-39.
19. Thonneau P, Fougeyrollas B, Ducot B, et al. Complications of abortion performed under local naesthesia. Eur J Obstet Gynecol Reprod Biol 1998; 81: 59-63. (Pubitemid 28464445)
20. Child TJ, Thomas J, Rees M, MacKenzie IZ. Morbidity of first trimester aspiration termination and the seniority of the surgeon. Hum Reprod 2001; 16: 875-78. (Pubitemid 32451821)
21. Warriner IK, Meirik O, Hoffman M, et al. Rates of complication in first-trimester manual vacuum aspiration done by doctors and mid-level providers in South Africa and Vietnam: a randomised controlled equivalence trial. Lancet 2006; 368: 1965-72. (Pubitemid 44830074)
22. Grimes DA, Cates W Jr. Complications from legally-induced abortion: a review. Obstet Gynecol Surv 1979; 34: 177-91. (Pubitemid 9130863)
23. Sawaya GF, Grady D, Kerlikowske K, Grimes DA. Antibiotics at the time of induced abortion: the case for universal prophylaxis based on a meta-analysis. Obstet Gynecol 1996; 87: 884-90. (Pubitemid 26127146)